간편결제 가능보고서 주문 후, 연도 업데이트와 커스터마이징을 위해 당사에서 연락드릴 예정입니다.
상세 사항에 따라 가격이 변동될 수 있으니 참고 바랍니다.
기본 보고서는 영문으로 작성되며, PDF,PPT,DOCX(워드) 형식으로 제공 가능합니다.
보고서 전달 후에는 환불이 불가능하오니 양해 바랍니다.
평균 납기는 2주이며, 형식과 내용에 따라 달라질 수 있습니다.
요약
2019 년 알츠하이머 의약품 시장 규모는 35 억 달러로 추정되며 2022-2027 년 예측 기간 동안 6.8% 의 성장률로 성장할 것으로 추정됩니다. 알츠하이머는 신경계 질환이며 가장 흔한 형태의 증상인 치매에는 기억 상실과 사고 기술 파괴, 문제 해결 또는 언어 장애 등이 포함됩니다
Summary
Alzheimer Drugs Market. Alzheimer’s Drugs Market size in 2019 is estimated to be $3.5 billion, growing at a CAGR of 6.8% during the forecast period 2022-2027. Alzheimer’s is a progressive neurological disease and most common form of dementia with symptoms includes memory loss and destroy thinking skills, difficulties with problem-solving or language
Table of Contents
1. Alzheimer’s Drugs Market Overview
1.1 Definitions and Scope
2. Alzheimer’s Drugs Market - Executive Summary
2.1 Market Size and Key Trends
2.2 Key trends by Drug Class
2.3 Key trends by Distribution Channel
2.4 Key trends by Geography
3. Alzheimer’s Drugs Market Landscape
3.1 Market Share Analysis - Key Companies
3.2 Product Benchmarking - Key Companies
3.3 Financial Analysis - Key Companies
3.4 Patent Analysis
3.5 Pricing Analysis
4. Alzheimer’s Drugs Market Forces
4.1 Market Drivers
4.2 Market Constraints/Challenges
4.3 Porters Five Force Model
4.3.1 Bargaining Power of Suppliers
4.3.2 Bargaining Powers of Customers
4.3.3 Threat of New Entrants
4.3.4 Rivalry Among Existing Players
4.3.5 Threat of Substitutes
5. Alzheimer’s Drugs Market - Strategic Analysis
5.1 Value Chain Analysis
5.2 Opportunities Analysis
5.3 Market Life Cycle
6. Alzheimer’s Drugs Market – By Drug Class (Market Size -$Million/$Billion)
6.1 Cholinergic
6.2 Memantine
6.3 Combined drug
6.4 Other drugs
7. Alzheimer’s Drugs Market – By Distribution Channel (Market Size -$Million/$Billion)
7.1 Hospital Pharmacy
7.2 Retail Pharmacy
7.3 Online Pharmacy
8. Alzheimer’s Drugs Market- By Geography (Market Size -$Million/$Billion)
8.1 North America
8.1.1 U.S.
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 U.K.
8.2.2 Germany
8.2.3 France
8.2.4 Italy
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia-Pacific
8.3.1 China
8.3.2 Japan
8.3.3 South Korea
8.3.4 India
8.3.5 Australia & New Zealand
8.3.6 Rest of Asia-Pacific
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Africa
8.4.3 South America
9. Alzheimer’s Drugs Market – Entropy
10. Alzheimer’s Drugs Market Company Analysis
10.1 Company Revenue, Products, M&A, Developments
10.2 Company 1
10.3 Company 2
10.4 Company 3
10.5 Company 4
10.6 Company 5
10.7 Company 6
10.8 Company 7
10.9 Company 8
10.10 Company 9
10.11 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
세금계산서 발행 문의
T. 070 8015 5940
보고서 주문 후, 연도 업데이트와 커스터마이징을 위해 당사에서 연락드릴 예정입니다.
상세 사항에 따라 가격이 변동될 수 있으니 참고 바랍니다.
기본 보고서는 영문으로 작성되며, PDF,PPT,DOCX(워드) 형식으로 제공 가능합니다.
보고서 전달 후에는 환불이 불가능하오니 양해 바랍니다.
평균 납기는 2주이며, 형식과 내용에 따라 달라질 수 있습니다.
요약
2019 년 알츠하이머 의약품 시장 규모는 35 억 달러로 추정되며 2022-2027 년 예측 기간 동안 6.8% 의 성장률로 성장할 것으로 추정됩니다. 알츠하이머는 신경계 질환이며 가장 흔한 형태의 증상인 치매에는 기억 상실과 사고 기술 파괴, 문제 해결 또는 언어 장애 등이 포함됩니다
Summary
Alzheimer Drugs Market. Alzheimer’s Drugs Market size in 2019 is estimated to be $3.5 billion, growing at a CAGR of 6.8% during the forecast period 2022-2027. Alzheimer’s is a progressive neurological disease and most common form of dementia with symptoms includes memory loss and destroy thinking skills, difficulties with problem-solving or language
Table of Contents
1. Alzheimer’s Drugs Market Overview
1.1 Definitions and Scope
2. Alzheimer’s Drugs Market - Executive Summary
2.1 Market Size and Key Trends
2.2 Key trends by Drug Class
2.3 Key trends by Distribution Channel
2.4 Key trends by Geography
3. Alzheimer’s Drugs Market Landscape
3.1 Market Share Analysis - Key Companies
3.2 Product Benchmarking - Key Companies
3.3 Financial Analysis - Key Companies
3.4 Patent Analysis
3.5 Pricing Analysis
4. Alzheimer’s Drugs Market Forces
4.1 Market Drivers
4.2 Market Constraints/Challenges
4.3 Porters Five Force Model
4.3.1 Bargaining Power of Suppliers
4.3.2 Bargaining Powers of Customers
4.3.3 Threat of New Entrants
4.3.4 Rivalry Among Existing Players
4.3.5 Threat of Substitutes
5. Alzheimer’s Drugs Market - Strategic Analysis
5.1 Value Chain Analysis
5.2 Opportunities Analysis
5.3 Market Life Cycle
6. Alzheimer’s Drugs Market – By Drug Class (Market Size -$Million/$Billion)
6.1 Cholinergic
6.2 Memantine
6.3 Combined drug
6.4 Other drugs
7. Alzheimer’s Drugs Market – By Distribution Channel (Market Size -$Million/$Billion)
7.1 Hospital Pharmacy
7.2 Retail Pharmacy
7.3 Online Pharmacy
8. Alzheimer’s Drugs Market- By Geography (Market Size -$Million/$Billion)
8.1 North America
8.1.1 U.S.
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 U.K.
8.2.2 Germany
8.2.3 France
8.2.4 Italy
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia-Pacific
8.3.1 China
8.3.2 Japan
8.3.3 South Korea
8.3.4 India
8.3.5 Australia & New Zealand
8.3.6 Rest of Asia-Pacific
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Africa
8.4.3 South America
9. Alzheimer’s Drugs Market – Entropy
10. Alzheimer’s Drugs Market Company Analysis
10.1 Company Revenue, Products, M&A, Developments
10.2 Company 1
10.3 Company 2
10.4 Company 3
10.5 Company 4
10.6 Company 5
10.7 Company 6
10.8 Company 7
10.9 Company 8
10.10 Company 9
10.11 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
